Sushanta is the President of Resilient Labs Inc, CEO of Ripple Biosolutions Inc. and CGO of TiVA Growth Inc. He is a founder and former CEO at Union Cannabis Group. Resilient Labs Inc is developing a wearable platform technology that will be IoT enabled, including sensors and applications that will have Rx and non-Rx drug delivery capabilities. Future generations of the device will assist in health care and military applications.TiVA Growth Inc. Is a multi-state operator of cannabis manufacturing and retail operations. One of their primary focuses is social justice and equality. Ripple Biosolutions Inc focuses on ecologically sustainable solutions, specifically composting, as opposed to recycling for consumer good packaging, natural food and supplements, the cannabis industry and beyond.Sushanta first started growing cannabis in 1995. His interest was captivated by the science and biology of the medical benefits of the plant, and that interest continued to grow as he started and ran large scale greenhouse cultivation facilities in Mendocino, CA. He was also the co-founder of a successful medical marijuana dispensary, VIP, with locations in Los Angeles and in Malibu. Throughout these experiences, Sushanta gained in-depth knowledge of cannabis production, manufacturing and distribution. In 2015, Sushanta led UCG’s efforts in establishing Dabstract -- a premier cannabis extraction brand -- in Washington, one of the first recreational states in the country. Today, UCG is operating the largest manufacturing facility in the state, and Dabstract is a leading connoisseur brand.Sushanta was also a co-founder of Austin Wellness Clinic, an integrative medical clinic in Austin, TX. As Director of Business Development, he helped develop a multi-million dollar operation and was a driving force behind the clinic’s nutraceutical division.Sushanta conducted ecological, genetic, and immunology research at the University of Texas at Austin. Today, he remains interested in ecological technologies, and the vast potential of the use of cannabinoids in nutraceutical and pharmaceutical formulations.